Polypeptide from Moschus Suppresses Lipopolysaccharide-Induced Inflammation by Inhibiting NF-κ B-ROS/NLRP3 Pathway

被引:0
|
作者
Jing Yi
Li Li
Zhu-jun Yin
Yun-yun Quan
Rui-rong Tan
Shi-long Chen
Ji-rui Lang
Jiao Li
Jin Zeng
Yong Li
Zi-jian Sun
Jun-ning Zhao
机构
[1] Southwest Medical University,Department of Pharmacology
[2] Sichuan Academy of Chinese Medicine Sciences,Sichuan Institute for Translational Chinese Medicine, Translational Chinese Medicine Key Laboratory of Sichuan Province
[3] Changsha Medical University,Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, College of Pharmacy
[4] Sichuan Fengchun Pharmaceutical Co.,undefined
[5] Ltd.,undefined
[6] Sichuan Ant Recommendation Biotechnology Co.,undefined
[7] Ltd.,undefined
关键词
polypeptide; inflammation; NLRP3 inflammasome; thioredoxin interacting protein; nuclear factor κB; Chinese medicine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:895 / 904
页数:9
相关论文
共 50 条
  • [1] Polypeptide from Moschus Suppresses Lipopolysaccharide-Induced Inflammation by Inhibiting NF-κB-ROS/NLRP3 Pathway
    Yi, Jing
    Li, Li
    Yin, Zhu-Jun
    Quan, Yun-Yun
    Tan, Rui-Rong
    Chen, Shi-Long
    Lang, Ji-Rui
    Li, Jiao
    Zeng, Jin
    Li, Yong
    Sun, Zi-Jian
    Zhao, Jun-Ning
    [J]. CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2023, 29 (10) : 895 - 904
  • [2] Polypeptide from Moschus Suppresses Lipopolysaccharide-Induced Inflammation by Inhibiting NF-κB-ROS/NLRP3 Pathway
    YI Jing
    LI Li
    YIN Zhujun
    QUAN Yunyun
    TAN Ruirong
    CHEN Shilong
    LANG Jirui
    LI Jiao
    ZENG Jin
    LI Yong
    SUN Zijian
    ZHAO Junning
    [J]. Chinese Journal of Integrative Medicine, 2023, 29 (10) : 895 - 904
  • [3] Polypeptide from Moschus Suppresses Lipopolysaccharide-Induced Inflammation by Inhibiting NF-κB-ROS/NLRP3 Pathway
    YI Jing
    LI Li
    YIN Zhu-jun
    QUAN Yun-yun
    TAN Rui-rong
    CHEN Shi-long
    LANG Ji-rui
    LI Jiao
    ZENG Jin
    LI Yong
    SUN Zi-jian
    ZHAO Jun-ning
    [J]. Chinese Journal of Integrative Medicine, 2023, (10) : 895 - 904
  • [4] Tetrandrine suppresses lipopolysaccharide-induced microglial activation by inhibiting NF-κB pathway
    Xue, Yang
    Wang, Ying
    Feng, De-chun
    Xiao, Bao-guo
    Xu, Ling-yun
    [J]. ACTA PHARMACOLOGICA SINICA, 2008, 29 (02) : 245 - 251
  • [5] Tetrandrine suppresses lipopolysaccharide-induced microglial activation by inhibiting NF-κB pathway
    Yang Xue
    Ying Wang
    De-chun Feng
    Bao-guo Xiao
    Ling-yun Xu
    [J]. Acta Pharmacologica Sinica, 2008, 29 : 245 - 251
  • [6] Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway
    Xiaohong Xu
    Xiaolin Huang
    Liexiang Zhang
    Xiaoli Huang
    Zihan Qin
    Fei Hua
    [J]. BMC Nephrology, 22
  • [7] Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway
    Xu, Xiaohong
    Huang, Xiaolin
    Zhang, Liexiang
    Huang, Xiaoli
    Qin, Zihan
    Hua, Fei
    [J]. BMC NEPHROLOGY, 2021, 22 (01)
  • [8] Aloin suppresses lipopolysaccharide-induced acute lung injury by inhibiting NLRP3/NF-κB via activation of SIRT1 in mice
    Lei, Jiaji
    Shen, Yongbin
    Xv, Guangquan
    Di, Zhixin
    Li, Yongchao
    Li, Guanghua
    [J]. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2020, 42 (04) : 306 - 313
  • [9] Thymopentin (TP-5) prevents lipopolysaccharide-induced neuroinflammation and dopaminergic neuron injury by inhibiting the NF-κB/NLRP3 signaling pathway
    Peng, Si-Jia
    Feng, Ya
    Li, Xuan
    Wang, Xi-Xi
    Wang, Yu
    Zhou, Bu-Tian
    Liu, Ye
    Liu, Te
    Wu, Yun-Cheng
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 119
  • [10] Ejiao ameliorates lipopolysaccharide-induced pulmonary inflammation via inhibition of NF?B regulating NLRP3 inflammasome and mitochondrial ROS
    Yue, Qingxi
    Zhang, Wen
    Lin, Shumeng
    Zheng, Tiansheng
    Hou, Yaqin
    Zhang, Yanfei
    Li, Ziye
    Wang, Kai
    Yue, Liduo
    Abay, Baigenzhin
    Li, Ming
    Fan, Lihong
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 152